Trade APLM anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Apollomics Inc. Class A (APLM) is trading at US$26.15, down 0.57% today as of Aug 28, 11:35 EDT. The company has a market capitalisation of US$70.45M. Over the past 52 weeks, APLM has traded between US$3.66 and US$42.12. On Syfe you can trade APLM with $0 commission and add it to your watchlist.
| Previous close | US$26.30 |
|---|---|
| Market cap | US$70.45M |
| 52-week range | US$3.66 – US$42.12 |
| Volume | 1.64K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Apollomics Inc. Class A
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in May 2015 and is headquartered in Foster City, CA.
Year: 2023
Apollomics Receives Nasdaq Deficiency Notice Over Market Value Requirement
Jun 24, 8:52 PM · MT Newswires
Apollomics Inc. Class A (APLM) stock is trading at US$26.15, -0.57% from the previous close of US$26.30.
The market cap for Apollomics Inc. Class A (APLM) stock is approximately US$70.45M.
The 52-week high for Apollomics Inc. Class A (APLM) stock is US$42.12.
The 52-week low for Apollomics Inc. Class A (APLM) stock is US$3.66.
Apollomics Inc. Class A (APLM) does not currently pay a dividend.
Stay on top of APLM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
